Laurus Labs

At 02:47 PM on Monday, the Nifty Pharma index was top loser among sectoral indices down 1.8% as against 0.3% rise in the Nifty 50.

Updated On: 16 Nov 2026 | 3:30 PM IST

Divi's Labs, Laurus Labs, Sai Life Sciences and Glenmark Pharma quoted at their respective record highs in Monday's trade.

Updated On: 09 Nov 2026 | 12:23 PM IST

Among others, Mankind Pharma, Ipca Laboratories, Torrent Pharmaceuticals, Divis Laboratories, Cipla and Aurobindo Pharma were up 2% each in Friday's trade.

Updated On: 30 Oct 2026 | 3:22 PM IST

Laurus Labs' share price hit a new high of ₹2,338.90, bouncing back 154% from its 52-week low of ₹917.95 touched on February 2, 2026.

Updated On: 30 Oct 2026 | 10:31 AM IST

Stocks to buy: MCX has formed a bullish candle, reclaimed the 50-DEMA and started making higher highs, indicating renewed buying interest, explains Chandan Taparia of Motilal Oswal.

Updated On: 28 Oct 2026 | 7:55 AM IST

FPIs increased stake in Laurus to 30.8% in the September 2026 quarter from 28% at the end of June 2026 quarter, shareholding data shows.

Updated On: 27 Oct 2026 | 3:24 PM IST

Laurus Labs Q2 outlook: On the EBITDA front, analysts at Kotak Institutional Equities build in 67% YoY growth to ₹680 crore in Q2FY27 with EBITDA margin expansion of 680 bps to 31.2%.

Updated On: 19 Oct 2026 | 12:50 PM IST

Divi's Laboratories remains the top pick for most brokerages in this segment, even as valuations turn rich after the sharp rally

Updated On: 11 Oct 2026 | 10:53 PM IST

The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.

Updated On: 21 Sep 2026 | 12:25 PM IST

Among the new additions, Laurus Labs saw its market-cap rise 92 per cent to ₹1.03 trillion from ₹53,546 crore as of March 30, 2026

Updated On: 01 Sep 2026 | 10:37 PM IST

The MSCI Standard Index will see four additions, Adani Energy Solutions, Billionbrains Garage Ventures, Laurus Labs, and Lenskart Solutions.

Updated On: 31 Aug 2026 | 12:06 PM IST

India's CRDMO sector growth rebounded to 19% YoY in Q1FY27 versus just 9% YoY in the March 2026 quarter, marking the highest growth level since the December 2024 quarter, notes Jefferies.

Updated On: 26 Aug 2026 | 11:22 AM IST

MSCI's August review adds four Indian companies and removes three, with India's index weight rising marginally to 11.9 per cent and constituents increasing to 166

Updated On: 13 Aug 2026 | 9:08 PM IST

In the past month, Laurus Labs outperformed the market by surging 22 per cent, as compared to 2.1 per cent rise in the Nifty Midcap 50 index.

Updated On: 06 Aug 2026 | 12:35 PM IST

Motilal Oswal's Chandan Taparia recommends Hero MotoCorp, Siemens, and Laurus Labs as technical buy ideas, citing bullish chart patterns, breakout formations, and strong sectoral momentum.

Updated On: 05 Aug 2026 | 7:38 AM IST

The BSE Healthcare hit a new high of 51,108 on Friday, rallying 3.7% in July. The index has surged 22% since April 2026.

Updated On: 31 Jul 2026 | 3:18 PM IST

Among others, Manappuram Finance, Marico, Radico Khaitan, Redington, Welspun Corp, Laurus Labs and Sai Life Sciences also touched respective all-time highs in trade on Thursday.

Updated On: 30 Jul 2026 | 12:32 PM IST

Laurus Labs quoted higher for the fourth straight day, surging 15% in this period after delivering record quarterly revenue with expanded profitability and continued portfolio transformation.

Updated On: 29 Jul 2026 | 12:15 PM IST

The stock price of Laurus Labs hit a new high of ₹1,662.45 in intra-day deals on Monday; the stock has zoomed 176% in the past 14 months from levels of ₹601.75 on May 27, 2025.

Updated On: 27 Jul 2026 | 10:19 AM IST

Laurus Labs on Friday reported a 124.7% YoY surge in Q1 consolidated net profit at ₹361.99 crore, backed by 28.8% growth in total income. The stock has nearly doubled in the last one year.

Updated On: 24 Jul 2026 | 3:25 PM IST